[DPHARMA] Change In Substantial Shareholder's Shareholding - EMPLOYEES PROVIDENT FUND BOARD on 26-Sep-2024

Announcement Date
26-Sep-2024
Director's Particular:
Details of Changes:
Currency
-
Date of ChangeTypeNumber of Shares
23-Sep-2024Acquired45,000
Registered Name
Citigroup Nominees (Tempatan) Sdn. Bhd.
Nature of Interest
Direct Interest
Nature Interest
Indirect Interest
Shares
Ordinary Shares
Reason
Acquisition of 45,000 shares by Citigroup Nominees (Tempatan) Sdn. Bhd. - Employees Provident Fund Board (KIB-ESG-EQ)
Total no of securities after change:
Direct (units)
0
Direct (%)
0.00
Indirect (units)
85,848,874
Indirect (%)
8.93
Total (units)
85,848,874
Total (%)
8.93
Date of Notice
24-Sep-2024
Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment